Apatinib With Pembrolizumab in Previously Treated Advanced Malignancies

Clinical trial NCT03407976 · TERMINATED

Trial details

NCT number: NCT03407976
Sponsor: University of Utah
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignancies Urothelial Carcinoma MSI-H or dMMR Solid Tumors Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Start date: 2018-06-19
Primary completion: 2019-08-19
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.